Article Information
History
- June 22, 2021.
Article Versions
- You are currently viewing Version 1 of this article (June 22, 2021 - 14:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xiaoyu Chea,b,*,
- Christopher R. Brydgesc,*,
- Yuanzhi Yub,
- Adam Pricea,
- Shreyas Joshia,
- Ayan Roya,
- Bohyun Leea,
- Dinesh K. Barupalc,
- Aaron Chenga,
- Dana March Palmerd,
- Susan Levinee,
- Daniel L. Petersonf,
- Suzanne D. Vernong,
- Lucinda Batemang,
- Mady Hornigd,
- Jose G. Montoyah,
- Anthony L. Komaroffi,
- Oliver Fiehnc,† and
- W. Ian Lipkina,†
- aCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
- bDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA
- cUC Davis Genome Center – Metabolomics, University of California, Davis, Davis, CA, USA
- dDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
- eLevine Clinic, New York, NY, USA
- fSierra Internal Medicine at Incline Village, Incline Village, NV, USA
- gBateman Horne Center, Salt Lake City, UT, USA
- hSutter Health Palo Alto Medical Foundation, Palo Alto, CA, USA
- iHarvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
- ↵†Corresponding authors: Oliver Fiehn, ofiehn{at}ucdavis.edu; W. Ian Lipkin, wil2001{at}cumc.columbia.edu
↵* Contributed equally
Posted June 22, 2021.
Dysregulation of the Kennedy Pathway and Tricarboxylic Acid Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
